Cargando…
Better drugs for Lyme disease: focus on the spirochete
Twenty-five years ago, the AIDS epidemic was wreaking havoc around the world. Although “HIV denialists” threatened to undermine research efforts to combat the epidemic, development of targeted antiviral therapy eventually provided effective treatment for the disease. Now the Lyme disease epidemic is...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136917/ https://www.ncbi.nlm.nih.gov/pubmed/30237727 http://dx.doi.org/10.2147/IDR.S176831 |
_version_ | 1783355091149914112 |
---|---|
author | Stricker, Raphael B Middelveen, Marianne J |
author_facet | Stricker, Raphael B Middelveen, Marianne J |
author_sort | Stricker, Raphael B |
collection | PubMed |
description | Twenty-five years ago, the AIDS epidemic was wreaking havoc around the world. Although “HIV denialists” threatened to undermine research efforts to combat the epidemic, development of targeted antiviral therapy eventually provided effective treatment for the disease. Now the Lyme disease epidemic is wreaking havoc around the world, and “Lyme denialists” are undermining efforts to combat the epidemic. Drawing on our experience with the AIDS epidemic, there is a significant need to develop targeted therapy to control the Lyme disease epidemic. |
format | Online Article Text |
id | pubmed-6136917 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-61369172018-09-20 Better drugs for Lyme disease: focus on the spirochete Stricker, Raphael B Middelveen, Marianne J Infect Drug Resist Commentary Twenty-five years ago, the AIDS epidemic was wreaking havoc around the world. Although “HIV denialists” threatened to undermine research efforts to combat the epidemic, development of targeted antiviral therapy eventually provided effective treatment for the disease. Now the Lyme disease epidemic is wreaking havoc around the world, and “Lyme denialists” are undermining efforts to combat the epidemic. Drawing on our experience with the AIDS epidemic, there is a significant need to develop targeted therapy to control the Lyme disease epidemic. Dove Medical Press 2018-09-07 /pmc/articles/PMC6136917/ /pubmed/30237727 http://dx.doi.org/10.2147/IDR.S176831 Text en © 2018 Stricker and Middelveen. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Commentary Stricker, Raphael B Middelveen, Marianne J Better drugs for Lyme disease: focus on the spirochete |
title | Better drugs for Lyme disease: focus on the spirochete |
title_full | Better drugs for Lyme disease: focus on the spirochete |
title_fullStr | Better drugs for Lyme disease: focus on the spirochete |
title_full_unstemmed | Better drugs for Lyme disease: focus on the spirochete |
title_short | Better drugs for Lyme disease: focus on the spirochete |
title_sort | better drugs for lyme disease: focus on the spirochete |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136917/ https://www.ncbi.nlm.nih.gov/pubmed/30237727 http://dx.doi.org/10.2147/IDR.S176831 |
work_keys_str_mv | AT strickerraphaelb betterdrugsforlymediseasefocusonthespirochete AT middelveenmariannej betterdrugsforlymediseasefocusonthespirochete |